The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq
Open accessAbstract
Hypoxia-inducible factor (HIF) regulates the major transcriptional cascade central to the response of all mammalian cells to alterations in oxygen tension. Expression arrays indicate that many hundreds of genes are regulated by this pathway, controlling diverse processes that in turn orchestrate both oxygen delivery and utilization. However, the extent to which HIF exerts direct versus indirect control over gene expression together with the factors dictating the range of HIF-regulated genes remains unclear. Using chromatin immunoprecipitation linked to high throughput sequencing, we identify HIF-binding sites across the genome, independently of gene architecture. Using gene set enrichment analysis, we demonstrate robust associations with the regulation of gene expression by HIF, indicating that these sites operate over long genomic intervals. Analysis of HIF-binding motifs demonstrates sequence preferences outside of the core RCGTG-binding motif but does not reveal any additional absolute sequence requirements. Across the entire genome, only a small proportion of these potential binding sites are bound by HIF, although occupancy of potential sites was enhanced approximately 20-fold at normoxic DNAse1 hypersensitivity sites (irrespective of distance from promoters), suggesting that epigenetic regulation of chromatin may have an important role in defining the response to hypoxia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A study using chromatin immunoprecipitation followed by next-generation high-throughput sequencing (ChIP-seq) showed that HIF binding sites exist outside of promoter sequences and that HIF binds to other sites as well as the core A/GCGTG motif (Schodel et al., 2011).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Schodel et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notwithstanding these distinctions, the global architecture of HIF-1- and HIF-2-dependent target gene networks remains largely conserved across different cell types [7,66,68,70]”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [68]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This was particularly true for HIF-2α, for which as many as 70% of the identified HIF-2 binding sites lay outside promoter regions.”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Schodel et al., 2011
The cited source says what the claim attributes to it.
In the citing paper
“Promoter-proximal HIF-1 binding correlates with a higher transcript abundance [68,71,79,82]”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [68]
The cited source says what the claim attributes to it.
In the citing paper
“Most functional HREs reside within open chromatin [68,80,81] and HIF-1 preferentially binds promoter-proximal regions, whereas HIF-2 more frequently occupies distal enhancers”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [68]
The cited source says what the claim attributes to it.
In the citing paper
“Within the nucleus, transcriptionally active HIF heterodimers bind hypoxia-responsive elements (HREs) containing an asymmetric E-box core motif (RCGTG, where R = A or G) [68,76]”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [68]
In the citing paper
“In the nucleus, HIF-α subunits dimerize with aryl hydrocarbon receptor nuclear translocator (ARNT) and bind to hypoxia-responsive elements in target genes to activate gene transcription by recruiting transcriptional coactivators including p300/CBP”
From Hypoxic control of metastasis (2016) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,836
Sequence logos: a new way to display consensus sequences
Schneider, T. D., & Stephens, R. M. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.20.6097 · Cited by 3,354
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251
Self-citationSemenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617
Oxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068
Self-citationAn oestrogen-receptor-α-bound human chromatin interactome
Fullwood, M. J., Liu, M. H., Pan, Y. F., Liu, J., Han, X., Mohamed, Y. B., Orlov, Y. L., Velkov, S., Ho, A., Poh, H. M., et al. (2009) · Nature · doi:10.1038/nature08497 · Cited by 1,752
Hypoxia signalling in cancer and approaches to enforce tumour regression
Pouysségur, J., Dayan, F., & Mazure, N. M. (2006) · Nature · doi:10.1038/nature04871 · Cited by 1,676
Sequencing of 50 Human Exomes Reveals Adaptation to High Altitude
Yi, X., Liang, Y., Huerta-Sanchez, E., Jin, X., Cuo, Z. X. P., Pool, J. E., Xu, X., Jiang, H., Vinckenbosch, N., Korneliussen, T. S., et al. (2010) · Science · doi:10.1126/science.1190371 · Cited by 1,611
Cited by
Sorted by citations
Items 101–200 of 719
Regulation of branched-chain amino acid metabolism by hypoxia-inducible factor in glioblastoma
Zhang, B., Chen, Y., Shi, X., Zhou, M., Bao, L., Hatanpaa, K. J., Patel, T., DeBerardinis, R. J., Wang, Y., & Luo, W. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03483-1 · Cited by 126
Hypoxia enhances lipid uptake in macrophages: Role of the scavenger receptors Lox1, SRA, and CD36
Crucet, M., Wüst, S., Spielmann, P., Lüscher, T. F., Wenger, R. H., & Matter, C. M. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.04.034 · Cited by 125
Hexokinase-2 Glycolytic Overload in Diabetes and Ischemia–Reperfusion Injury
Rabbani, N., & Thornalley, P. J. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.04.011 · Cited by 126
The SIN3A histone deacetylase complex is required for a complete transcriptional response to hypoxia
Tiana, M., Acosta‐Iborra, B., Puente-Santamaría, L., Hernansanz‐Agustín, P., Worsley-Hunt, R., Masson, N., Rio, F. G., Mole, D. R., Ratcliffe, P. J., Wasserman, W. W., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx951 · Cited by 124
Self-citationChromatin as an oxygen sensor and active player in the hypoxia response
Melvin, A., & Rocha, S. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.08.019 · Cited by 123
Straus, D. S. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-78 · Cited by 124
Cell cycle progression in response to oxygen levels
Ortmann, B. M., Druker, J., & Rocha, S. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1645-9 · Cited by 131
Chakraborty, D., Cui, W., Rosario, G. X., Scott, R. L., Dhakal, P., Renaud, S. J., Tachibana, M., Rumi, M. A. K., Mason, C., Krieg, A. J., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612626113 · Cited by 124
High-Resolution Genome-wide Mapping of AHR and ARNT Binding Sites by ChIP-Seq
Lo, R., & Matthews, J. B. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs253 · Cited by 124
The role of hypoxia‐inducible factor‐2 alpha in angiogenesis
Befani, C. D., & Liakos, P. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26805 · Cited by 129
Leukemia stem cells in T-ALL require active Hif1α and Wnt signaling
Giambra, V., Jenkins, C. E., Lam, S. H. L., Hoofd, C., Belmonte, M., Wang, X., Gusscott, S., Gracias, D., & Weng, A. P. (2015) · Blood · doi:10.1182/blood-2014-10-609370 · Cited by 116
Advances in promoter engineering: Novel applications and predefined transcriptional control
Cazier, A. P., & Blazeck, J. (2021) · Biotechnology Journal · doi:10.1002/biot.202100239 · Cited by 118
Ede, C., Chen, X., Lin, M.-Y., & Chen, Y. Y. (2016) · ACS Synthetic Biology · doi:10.1021/acssynbio.5b00266 · Cited by 119
Erythrocytosis: the HIF pathway in control
Franke, K., Gassmann, M., & Wielockx, B. (2013) · Blood · doi:10.1182/blood-2013-01-478065 · Cited by 117
Molecular Responses to Hypoxia-Inducible Factor 1α and Beyond
Brocato, J., Chervona, Y., & Costa, M. (2014) · Molecular Pharmacology · doi:10.1124/mol.113.089623 · Cited by 114
Chan, M. C., Ilott, N. E., Schödel, J., Sims, D., Tumber, A., Lippl, K., Mole, D. R., Pugh, C. W., Ratcliffe, P. J., Ponting, C. P., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.749291 · Cited by 113
Self-citationJežek, P., Jabůrek, M., Holendová, B., Engstová, H., & Dlasková, A. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0173 · Cited by 117
Gremlin Plays a Key Role in the Pathogenesis of Pulmonary Hypertension
Cahill, E., Costello, C. M., Rowan, S. C., Harkin, S., Howell, K., Leonard, M. O., Southwood, M. R., Cummins, E. P., Fitzpatrick, S. F., Taylor, C. T., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.038125 · Cited by 110
Kobayashi, H., Gilbert, V., Liu, Q., Kapitsinou, P. P., Unger, T. L., Rha, J., Rivella, S., Schlöndorff, D., & Haase, V. H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103377 · Cited by 111
Regulation Is in the Air: The Relationship between Hypoxia and Epigenetics in Cancer
Camuzi, D., de Amorim, Í. S. S., Pinto, L. F. R., Trivilin, L. O., Mencalha, A. L., & Soares‐Lima, S. C. (2019) · Cells · doi:10.3390/cells8040300 · Cited by 109
The role of HIF1α in renal cell carcinoma tumorigenesis
Gudas, L. J., Fu, L., Minton, D. R., Mongan, N. P., & Nanus, D. M. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1180-z · Cited by 106
Broekgaarden, M., Weijer, R., Krekorian, M., van den IJssel, B., Kos, M., Alles, L. K., van Wijk, A. C. W. A., Bikádi, Z., Hazai, E., van Gulik, T. M., et al. (2016) · Nano Research · doi:10.1007/s12274-016-1059-0 · Cited by 101
Kim, H., Shim, B. Y., Lee, S., Lee, J. Y., Lee, H. J., & Kim, I.-H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189795 · Cited by 109
Hypoxia/HIF Modulates Immune Responses
Chen, Y., & Gaber, T. (2021) · Biomedicines · doi:10.3390/biomedicines9030260 · Cited by 100
Metabolic Regulation in the Induction of Trained Immunity
Ferreira, A. V., Domínguez‐Andrés, J., Pich, L. M. M., Joosten, L. A. B., & Netea, M. G. (2024) · Seminars in Immunopathology · doi:10.1007/s00281-024-01015-8 · Cited by 104
Activation of Dopamine Receptor 2 Prompts Transcriptomic and Metabolic Plasticity in Glioblastoma
Caragher, S. P., Shireman, J. M., Huang, M., Miska, J. M., Atashi, F., Baisiwala, S., Park, C. H., Saathoff, M. R., Warnke, L., Xiao, T., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1589-18.2018 · Cited by 101
Role of Intestinal HIF-2α in Health and Disease
Ramakrishnan, S. K., & Shah, Y. M. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105202 · Cited by 100
Valzania, L., Coon, K. L., Vogel, K. J., Brown, M. R., & Strand, M. R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1719063115 · Cited by 99
Azimi, I., Milevskiy, M. J. G., Kaemmerer, E., Turner, D., Yapa, K. T. D. S., Brown, M. A., Thompson, E. W., Roberts‐Thomson, S. J., & Monteith, G. R. (2017) · Journal of Cell Science · doi:10.1242/jcs.196659 · Cited by 97
The multifaceted von Hippel–Lindau tumour suppressor protein
Robinson, C. M., & Ohh, M. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.02.026 · Cited by 101
Hao, X., Ren, Y., Feng, M., Wang, Q., & Wang, Y. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111798 · Cited by 101
HIF2α in the uterine stroma permits embryo invasion and luminal epithelium detachment
Matsumoto, L., Hirota, Y., Saito‐Fujita, T., Takeda, N., Tanaka, T., Hiraoka, T., Akaeda, S., Fujita, H., Shimizu‐Hirota, R., Igaue, S., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98931 · Cited by 95
Molecular Portrait of Hypoxia in Breast Cancer: A Prognostic Signature and Novel HIF-Regulated Genes
Ye, I. C., Fertig, E. J., DiGiacomo, J. W., Considine, M., Godet, I., & Gilkes, D. M. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0345 · Cited by 96
Chambers, A. M., & Matosevic, S. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00060 · Cited by 100
The HIF and other quandaries in VHL disease
Tarade, D., & Ohh, M. (2017) · Oncogene · doi:10.1038/onc.2017.338 · Cited by 93
Ariazi, J. L., Duffy, K. J., Adams, D. F., Fitch, D. M., Luo, L., Pappalardi, M. B., Biju, M. P., DiFilippo, E. H., Shaw, T., Wiggall, K., et al. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.242503 · Cited by 94
Aro, E., Khatri, R., Gerard-O’Riley, R. L., Mangiavini, L., Myllyharju, J., & Schipani, E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.352872 · Cited by 98
Copper affects the binding of HIF-1α to the critical motifs of its target genes
Wu, Z., Zhang, W., & Kang, Y. J. (2018) · Metallomics · doi:10.1039/c8mt00280k · Cited by 93
Slemc, L., & Kunej, T. (2016) · Tumor Biology · doi:10.1007/s13277-016-5331-4 · Cited by 94
Isoform-Selective and Stereoselective Inhibition of Hypoxia Inducible Factor-2
Scheuermann, T. H., Stroud, D., Sleet, C. E., Bayeh, L., Shokri, C., Wang, H., Caldwell, C. G., Longgood, J. C., MacMillan, J. B., Bruick, R. K., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00529 · Cited by 92
Baumann, B., Hayashida, T., Liang, X., & Schnaper, H. W. (2016) · Kidney International · doi:10.1016/j.kint.2016.05.026 · Cited by 90
Mitochondria bridge HIF signaling and ferroptosis blockage in acute kidney injury
Li, W., Xiang, Z., Xing, Y., Shen, L., & Shi, S. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04770-4 · Cited by 90
Grampp, S., Platt, J. L., Lauer, V., Salama, R. A., Kranz, F., Neumann, V. K., Wach, S., Stöhr, C., Hartmann, A., Eckardt, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms13183 · Cited by 88
Self-citationPelster, B., & Egg, M. (2018) · Journal of Experimental Biology · doi:10.1242/jeb.163709 · Cited by 91
The role of hypoxia-inducible factors in cardiovascular diseases
Yu, B., Wang, X., Song, Y., Xie, G., Jiao, S., Shi, L., Cao, X., Han, X., & Qu, A. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108186 · Cited by 88
HIF-1-Dependent Induction of Jumonji Domain-Containing Protein (JMJD) 3 under Hypoxic Conditions
Lee, H.-Y., Choi, K. Y., Oh, H., Park, Y.-K., & Park, H. (2014) · Molecules and Cells · doi:10.14348/molcells.2014.2250 · Cited by 86
Hypoxia and Bone Metastatic Disease
Johnson, R. W., Sowder, M. E., & Giaccia, A. J. (2017) · Current Osteoporosis Reports · doi:10.1007/s11914-017-0378-8 · Cited by 92
Perron, G., Jandaghi, P., Solanki, S., Safisamghabadi, M., Storoz, C., Karimzadeh, M., Papadakis, A. I., Arseneault, M., Scélo, G., Banks, R. E., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.031 · Cited by 86
Hodson, E. J., Nicholls, L. G., Turner, P. J., Llyr, R., Fielding, J. W., Douglas, G., Ratnayaka, I., Robbins, P. A., Pugh, C. W., Buckler, K. J., et al. (2015) · The Journal of Physiology · doi:10.1113/jp271050 · Cited by 84
Self-citationDavis, L., Recktenwald, M., Hutt, E., Fuller, S., Briggs, M., Goel, A., & Daringer, N. (2022) · Cancers · doi:10.3390/cancers14051259 · Cited by 83
Pawlus, M. R., & Hu, C. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.05.018 · Cited by 85
Zhao, Y., Liu, M., Chan, X. Y., Tan, S. Y., Subramaniam, S., Fan, Y., Loh, E., Chang, K. T. E., Tan, T. C., & Chen, Q. (2017) · Blood · doi:10.1182/blood-2017-04-778779 · Cited by 83
Systemic Reprogramming of Translation Efficiencies on Oxygen Stimulus
Ho, J. J. D., Wang, M., Audas, T. E., Kwon, D., Carlsson, S. K., Timpano, S., Evagelou, S. L., Brothers, S. P., Gonzalgo, M. L., Krieger, J. R., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.036 · Cited by 86
REST is a hypoxia-responsive transcriptional repressor
Cavadas, M. A. S., Mesnieres, M., Crifò, B., Manresa, M. C., Selfridge, A. C., Keogh, C. E., Fábián, Z., Scholz, C. C., Nolan, K. A., Rocha, L. M. A., et al. (2016) · Scientific Reports · doi:10.1038/srep31355 · Cited by 81
Bowler, E., Porazinski, S. R., Uzor, S., Thibault, P., Durand, M., Lapointe, E., Rouschop, K. M. A., Hancock, J. T., Wilson, I. D., & Ladomery, M. (2018) · BMC Cancer · doi:10.1186/s12885-018-4227-7 · Cited by 81
Ruf, M., Mittmann, C., Nowicka, A. M., Hartmann, A., Hermanns, T., Poyet, C., van den Broek, M. F., Sulser, T., Moch, H., & Schraml, P. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1425 · Cited by 86
Ortmann, B. M., Burrows, N., Lobb, I. T., Arnaiz, E., Wit, N., Bailey, P. S. J., Jordon, L., Lombardi, O., Peñalver, A., McCaffrey, J., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00887-y · Cited by 83
Self-citationHypoxia is a Key Driver of Alternative Splicing in Human Breast Cancer Cells
Han, J., Li, J., Ho, J. C., Chia, G. S., Kato, H., Jha, S., Yang, H. H., Poellinger, L., & Lee, K. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-04333-0 · Cited by 84
Dzhalilova, D. S., & Makarova, O. V. (2020) · Biomedicines · doi:10.3390/biomedicines8100428 · Cited by 79
NRF2 and Hypoxia-Inducible Factors: Key Players in the Redox Control of Systemic Iron Homeostasis
Duarte, T. L., Talbot, N. P., & Drakesmith, H. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8148 · Cited by 77
NCOA4 is Regulated by HIF and Mediates Mobilization of Murine Hepatic Iron Stores After Blood Loss
Li, X., Lozovatsky, L., Sukumaran, A., Gonzalez, L. A., Jain, A., Liu, D., Ayala‐Lopez, N., & Finberg, K. E. (2020) · Blood · doi:10.1182/blood.2020006321 · Cited by 75
Hif-1α and Hif-2α synergize to suppress AML development but are dispensable for disease maintenance
Vukovic, M., Guitart, A. V., Sepúlveda, C., Villacreces, A., O’Duibhir, E., Panagopoulou, T. I., Ivens, A. C., Menendez-Gonzalez, J. B., Iglesias, J. M., Allen, L., et al. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20150452 · Cited by 81
Self-citationHIF1 mediates a switch in pyruvate kinase isoforms after myocardial infarction
Williams, A. L., Khadka, V. S., Tang, M., Avelar, A., Schunke, K. J., Menor, M., & Shohet, R. V. (2018) · Physiological Genomics · doi:10.1152/physiolgenomics.00130.2017 · Cited by 79
D’Anna, F., Dyck, L. V., Xiong, J., Zhao, H., Berrens, R. V., Qian, J., Bieniasz-Krzywiec, P., Chandra, V., Schoonjans, L., Matthews, J. B., et al. (2020) · Genome biology · doi:10.1186/s13059-020-02087-z · Cited by 76
Hypoxia and Oxygen-Sensing Signaling in Gene Regulation and Cancer Progression
Yang, G., Shi, R., & Zhang, Q. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218162 · Cited by 78
HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer
Jarman, E. J., Ward, C., Turnbull, A., Martínez-Pérez, C., Meehan, J., Xintaropoulou, C., Sims, A. H., & Langdon, S. P. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1097-0 · Cited by 76
Azimi, I., Milevskiy, M. J. G., Chalmers, S. B., Yapa, K. T. D. S., Robitaille, M., Henry, C., Baillie, G. J., Thompson, E. W., Roberts‐Thomson, S. J., & Monteith, G. R. (2019) · Cancers · doi:10.3390/cancers11020208 · Cited by 72
Yaghi, L., Poras, I., Simões, R. T., Donadi, E. A., Tost, J., Daunay, A., de Almeida, B. S., Carosella, E. D., & Moreau, P. (2016) · Oncotarget · doi:10.18632/oncotarget.11628 · Cited by 71
Capture‐C reveals preformed chromatin interactions between HIF‐binding sites and distant promoters
Platt, J. L., Salama, R. A., Smythies, J., Choudhry, H., Davies, J. O. J., Hughes, J. R., Ratcliffe, P. J., & Mole, D. R. (2016) · EMBO Reports · doi:10.15252/embr.201642198 · Cited by 72
Self-citationHypoxia Signaling Pathway in Stem Cell Regulation: Good and Evil
Huang, X., Trinh, T. L. P., Aljoufi, A., & Broxmeyer, H. E. (2018) · Current Stem Cell Reports · doi:10.1007/s40778-018-0127-7 · Cited by 72
HIF-1 and HIF-2 in cancer: structure, regulation, and therapeutic prospects
Shi, Y., & Gilkes, D. M. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05537-0 · Cited by 81
PHD2: from hypoxia regulation to disease progression
Wielockx, B., & Meneses, A. (2016) · Hypoxia · doi:10.2147/hp.s53576 · Cited by 72
Hypoxic Regulation of Gene Transcription and Chromatin: Cause and Effect
Kindrick, J. D., & Mole, D. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218320 · Cited by 67
Self-citationWu, D., Dasgupta, A., Read, A. D., Bentley, R. E. T., Motamed, M., Chen, K., Al‐Qazazi, R., Mewburn, J. D., Dunham‐Snary, K. J., Alizadeh, E., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.12.452 · Cited by 69
Activation of γ-globin expression by hypoxia-inducible factor 1α
Feng, R., Mayuranathan, T., Huang, P., Doerfler, P. A., Li, Y., Yao, Y., Zhang, J., Palmer, L. E., Mayberry, K. D., Christakopoulos, G. E., et al. (2022) · Nature · doi:10.1038/s41586-022-05312-w · Cited by 69
HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapy
Jiang, Q., Braun, D. A., Clauser, K. R., Ramesh, V., Shirole, N. H., Duke-Cohan, J. E., Nabilsi, N., Kramer, N. J., Forman, C., Lippincott, I. E., et al. (2025) · Cell · doi:10.1016/j.cell.2025.01.046 · Cited by 68
Weijer, R., Broekgaarden, M., Krekorian, M., Alles, L. K., van Wijk, A. C., Mackaaij, C., Verheij, J., van der Wal, A. C., van Gulik, T. M., Storm, G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6490 · Cited by 67
Bioenergetic dysfunction in the pathogenesis of intervertebral disc degeneration
Song, C., Hu, P., Peng, R., Li, F., Fang, Z., & Xu, Y. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107119 · Cited by 69
Hypoxia drives the assembly of the multienzyme purinosome complex
Doigneaux, C., Pedley, A. M., Mistry, I. N., Papayova, M., Benkovic, S. J., & Tavassoli, A. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012175 · Cited by 65
Peng, T., Du, S.-Y., Son, M., & Diamond, B. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2106017118 · Cited by 67
Role of hypoxia in progressive chronic kidney disease and implications for therapy
Shoji, K., Tanaka, T., & Nangaku, M. (2013) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000441049.98664.6c · Cited by 66
Regulation of hypoxia-inducible gene expression after HIF activation
Suzuki, N., Gradin, K., Poellinger, L., & Yamamoto, M. P. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.03.013 · Cited by 68
A network of RNA-binding proteins controls translation efficiency to activate anaerobic metabolism
Ho, J. J. D., Balukoff, N. C., Theodoridis, P. R., Wang, M., Krieger, J. R., Schatz, J. H., & Lee, S. (2020) · Nature Communications · doi:10.1038/s41467-020-16504-1 · Cited by 66
The Circadian Clock Protein CRY1 Is a Negative Regulator of HIF-1α
Dimova, E. Y., Jakupović, M., Kubaichuk, K. I., Mennerich, D., Chi, T. F., Tamanini, F., Oklejewicz, M., Hänig, J., Byts, N., Mäkelä, K. A., et al. (2019) · iScience · doi:10.1016/j.isci.2019.02.027 · Cited by 66
Andrysik, Z., Bender, H., Galbraith, M. D., & Espinosa, J. M. (2021) · Nature Communications · doi:10.1038/s41467-021-21687-2 · Cited by 63
Tolonen, J.-P., Heikkilä, M., Malinen, M., Lee, H.-M., Palvimo, J. J., Wei, G.-H., & Myllyharju, J. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03387-9 · Cited by 63
Bishop, T., Talbot, N. P., Turner, P. J., Nicholls, L. G., Pascual, A., Hodson, E. J., Douglas, G., Fielding, J. W., Smith, T. G., Demetriades, M., et al. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2012.247254 · Cited by 64
Self-citationNon-canonical Targets of HIF1a Impair Oligodendrocyte Progenitor Cell Function
Allan, K. C., Hu, L. R., Scavuzzo, M. A., Morton, A. R., Gevorgyan, A. S., Cohn, E. F., Clayton, B. L. L., Bederman, I. R., Hung, S., Bartels, C. F., et al. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.09.019 · Cited by 59
Martí, J. M., García-Díaz, Á., Delgado‐Bellido, D., O’Valle, F., González-Flores, A., Carlevaris, O., Rodríguez-Vargas, J. M., Amé, J., Dantzer, F., King, G. L., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101885 · Cited by 64
Epigenetic programming of hypoxic–ischemic encephalopathy in response to fetal hypoxia
Ma, Q., & Zhang, L. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.11.001 · Cited by 63
BDNF rs6265 methylation and genotype interact on risk for schizophrenia
Ursini, G., Cavalleri, T., Fazio, L., Angrisano, T., Iacovelli, L., Porcelli, A., Maddalena, G., Punzi, G., Mancini, M., Gelao, B., et al. (2016) · Epigenetics · doi:10.1080/15592294.2015.1117736 · Cited by 62
Understanding the Oxygen-Sensing Pathway and Its Therapeutic Implications in Diseases
Liao, C., & Zhang, Q. H. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.04.003 · Cited by 64
HIF1α promotes tumor chemoresistance via recruiting GDF15-producing TAMs in colorectal cancer
Zheng, H., Yu, S., Zhu, C., Guo, T., Liu, F., & Xu, Y. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112394 · Cited by 61
The transcriptional and regulatory identity of erythropoietin producing cells
Kragesteen, B. K., Giladi, A., David, E., Halevi, S., Geirsdóttir, L., Lempke, O. M., Li, B., Bapst, A. M., Xie, K., Katzenelenbogen, Y., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02314-7 · Cited by 67
The cardiac hypoxic niche: emerging role of hypoxic microenvironment in cardiac progenitors.
Kimura, W., & Sadek, H. A. (2012) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2223-3652.2012.12.02 · Cited by 61
Hypoxia in the Eye: A Two-Sided Coin
Grimm, C., & Willmann, G. (2012) · High Altitude Medicine & Biology · doi:10.1089/ham.2012.1031 · Cited by 62
Niskanen, H., Tuszyńska, I., Zaborowski, R., Heinäniemi, M., Ylä‐Herttuala, S., Wilczyński, B., & Kaikkonen, M. U. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1214 · Cited by 63
Control of the Antitumor Immune Response by Cancer Metabolism
Domblides, C., Lartigue, L., & Faustin, B. (2019) · Cells · doi:10.3390/cells8020104 · Cited by 64
Bae, Y.-H., Joo, H., Bae, J., Hyeon, S. J., Her, S., Ko, E., Choi, H. G., Ryu, H., Hur, E., Bu, Y., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1180-y · Cited by 62
Mechanisms governing target search and binding dynamics of hypoxia-inducible factors
Chen, Y., Cattoglio, C., Dailey, G. M., Zhu, Q., Tjian, R., & Darzacq, X. (2022) · eLife · doi:10.7554/elife.75064 · Cited by 60
Metadata
- Authors
- Schödel, J., Oikonomopoulos, S., Ragoussis, J., Pugh, C. W., Ratcliffe, P. J., & Mole, D. R.
- Affiliations
- University of Oxford (GB)
- Centre for Human Genetics (GB)
- ORCID
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2011-06-09
- Volume
- 117
- Issue
- 23
- Pages
- e207-e217
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC3374576
- OpenAlex
- W1969734439
- Cited by
- 724
- References
- 50
- Citations by year
- 2026: 25 · 2025: 34 · 2024: 32 · 2023: 43 · 2022: 63 · 2021: 72 · 2020: 62 · 2019: 55 · 2018: 45 · 2017: 52 · 2016: 56 · 2015: 44 · 2014: 50 · 2013: 61 · 2012: 22
- FWCI
- 15.34
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Blood (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (090532)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- hypoxia-inducible factor, transcriptional regulation, hypoxia response, oxygen partial pressure, chromatin accessibility, epigenetic regulation, gene set enrichment analysis, sequence motifs
- MeSH terms
- Chromosome Mapping, Female, Humans, Oxygen, Genome, Human, Response Elements, Epigenesis, Genetic, Cell Line, Tumor, Chromatin Immunoprecipitation, Basic Helix-Loop-Helix Proteins, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
